Search

Your search keyword '"Guymer, Robyn"' showing total 1,476 results

Search Constraints

Start Over You searched for: Author "Guymer, Robyn" Remove constraint Author: "Guymer, Robyn"
1,476 results on '"Guymer, Robyn"'

Search Results

5. A deep learning framework for the detection and quantification of drusen and reticular pseudodrusen on optical coherence tomography

12. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

13. TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2

16. Role of anti-vascular endothelial growth factor in the management of non-proliferative diabetic retinopathy without centre-involving diabetic macular oedema: a meta-analysis of trials

18. Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical Practice

23. Randomized Phase 2b Study of Brimonidine Drug Delivery System Generation 2 for Geographic Atrophy in Age-related Macular Degeneration

24. Weakly Supervised Lesion Localization of Nascent Geographic Atrophy in Age-Related Macular Degeneration

26. Reticular Pseudodrusen: Interreader Agreement of Evaluation on OCT Imaging in Age-Related Macular Degeneration

36. Replenishing IRAK-M expression in retinal pigment epithelium attenuates outer retinal degeneration

38. RWC Update: Removal of Subretinal Band Without Retinotomy; Geographic Atrophy: How Do You Select Appropriate Patients for Anti-Complement Therapy?; Shaken Baby Syndrome

40. Effect of Ciliary Neurotrophic Factor on Retinal Neurodegeneration in Patients with Macular Telangiectasia Type 2 A Randomized Clinical Trial

43. Transcriptomic and proteomic retinal pigment epithelium signatures of age-related macular degeneration

45. Clinical performance of predicting late age‐related macular degeneration development using multimodal imaging.

46. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials

47. Effect of Low-Dose Aspirin on the Course of Age-Related Macular Degeneration

Catalog

Books, media, physical & digital resources